Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

BACKGROUND/AIMS: Hepatic damage during transarterial chemoembolization (TACE) is a critical complication in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Apart from its role in preventing HBV reactivation, there is some evidence for the benefits of preemptive antivira...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Mol Hepatol
Autors principals: Yoo, Sun Hong, Jang, Jeong Won, Kwon, Jung Hyun, Jung, Seung Min, Jang, Bohyun, Choi, Jong Young
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266345/
https://ncbi.nlm.nih.gov/pubmed/28081589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars